Your browser doesn't support javascript.
loading
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries.
Canales Albendea, Miguel Á; Canonico, Pier Luigi; Cartron, Guillaume; Deiters, Barthold; Jommi, Claudio; Marks, Reinhard; Rioufol, Catherine; Sancho Cia, Juan M; Santoro, Armando; Wagner-Drouet, Eva M.
Affiliation
  • Canales Albendea MÁ; Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Canonico PL; Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy.
  • Cartron G; Centre Hospitalier Universitaire de Montpellier, UMR-CNRS 5535, Montpellier, France.
  • Deiters B; GWQ ServicePlus AG, Düsseldorf, Germany.
  • Jommi C; Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy.
  • Marks R; Department of Medicine I, Medical Center, University of Freiburg, Freiburg, Germany.
  • Rioufol C; Department of Pharmacy, Lyon Sud Hospital, Hospices Civils de Lyon, Lyon, France.
  • Sancho Cia JM; EA 3738 Center for Innovation in Cancerology of Lyon (CICLY)-Claude Bernard University Lyon I, Lyon, France.
  • Santoro A; ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Spain.
  • Wagner-Drouet EM; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Front Med (Lausanne) ; 10: 1128295, 2023.
Article in En | MEDLINE | ID: mdl-37324138

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Risk_factors_studies Language: En Journal: Front Med (Lausanne) Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Risk_factors_studies Language: En Journal: Front Med (Lausanne) Year: 2023 Document type: Article Affiliation country: